Shingrix vial kits
Ended Awarded Last action
- Contract number
- SPE2DR26F9Q4X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,588
Award facts
- Contract value 100% obligated
- $9,587.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $9,587.57 for Shingrix vial kits by the Defense Logistics Agency (DLA) on January 2, 2026, with a completion deadline of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for federal military healthcare programs.
Shingrix, a recombinant zoster vaccine, addresses critical immunization requirements within the Defense Health Agency and broader federal healthcare systems. This delivery order demonstrates AmerisourceBergen's continued role as a strategic pharmaceutical distributor within the DLA's Medical Supply Chain, supporting military personnel and veteran healthcare needs. The company's extensive federal contract portfolio reflects its capability to fulfill open competition procurement requirements across diverse pharmaceutical products and medical supplies, positioning it as a key vendor for federal medical logistics as the DLA prepares to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions.
Quick answers
Who was awarded contract SPE2DR26F9Q4X?
SPE2DR26F9Q4X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9Q4X worth?
The government has obligated $9,588 on SPE2DR26F9Q4X.
Is contract SPE2DR26F9Q4X an order under another contract?
Yes. SPE2DR26F9Q4X is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9Q4X competed?
The extent of competition for SPE2DR26F9Q4X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award